An analysis of redactions in Canada’s Common Drug Review Clinical Review Reports and how they relate to the patients’ voice

Documenti analoghi

• The frequency and availability of population-specific patient reported outcome measures and minimal clinically important differences among approved drugs in Canada
  di: Allison Soprovich, et al.
  Pubblicazione: (2019-01-01)
• The frequency and availability of population-specific patient reported outcome measures and minimal clinically important differences among approved drugs in Canada
  di: Soprovich, Allison, et al.
  Pubblicazione: (2019)
• Analysis of drug coverage before and after the implementation of Canada’s Common Drug Review
  di: Gamble, John-Michael, et al.
  Pubblicazione: (2011)
• Comparison of drug coverage in Canada before and after the establishment of the pan-Canadian Pharmaceutical Alliance
  di: Milliken, Debbie, et al.
  Pubblicazione: (2015)
• A Comparison of Drug Coverage in Alberta Before and After the Introduction of the National Common Drug Review Process
  di: Gamble, John-Michael, et al.
  Pubblicazione: (2010)